
This week on MDNN: The SELECT-COMPARE trial reported positive results for upadacitinib, older adults in the US are not being tested for HIV, and the shifting trends in US mortality.

This week on MDNN: The SELECT-COMPARE trial reported positive results for upadacitinib, older adults in the US are not being tested for HIV, and the shifting trends in US mortality.

Daptomycin for injection is an affordable generic antibiotic alternative to Cubicin.

Next generation sequencing technology is coming on strong in the clinical setting. The FDA would like to help it better reach the market.

Researchers can agree that medical errors are a big problem in the US. But can they agree on its pathology?

The Global Burden of Disease study found that US mortality has improved since 1990 — but has been caused by worse health measures.

Patients must also receive a brochure and sign risk acknowledgment.

How taking time to reflect after the loss of a patient can help physicians endure everyday loss.

Global studies show the practice is still rare, but growing in countries to have legalized it.

This week on MDNN: Physician report being unaware of how many opioids they prescribe, legalized marijuana cuts down on opioid rates in Medicaid patients, Grindr responds to leak they share users' HIV statuses, and the FDA recalls salmonella-containing kratom.

Legislators and a libertarian think-tank have flaunted the merits of the Right-to-Try experimental drug policy. But physicians question its value and the message it sends to patients.

In a first-time issuance, all food products containing powdered kratom from Triangle Pharmanaturals, have been ordered to be recalled due to samples containing salmonella bacteria.

Researchers observed that prescribing rates were cut by about 6% in at-risk populations from states with legalization laws in place.

The 27-year Navy veteran will assume clinical and administrative roles with the country's largest clinical research-focused hospital.

When a physician becomes famous, opportunities abound. How can they ensure they’re leveraging the limelight responsibly?

This week on MDNN: Neonatal abstinence syndrome increases by 433% over a decade, CDC reports opioid deaths are driven by synthetic strains, and drug use disorder mortality accounts for 4% of all 2015 deaths.

Science has begun to lean on P values as the gold standard for study results, which has led to the misconception that statistical significance equals truth.

Results contradicted previous studies that did not account for baseline differences between DAA- and interferon-treated patients.

How the nation’s excessive spending and poor health outcomes drove researchers to seek solutions.

The approved use of a direct-acting antiviral combination for 8 weeks to treat HCV genotypes 1 and 3 was supported by data from over 1200 patients.

Integrating transgender-specific content into medical curricula improves student knowledge and comfort with transgender medical care.

As those age 65 and older face more serious illness, unprecedented burdens to serve a burgeoning population in need of high quality, coordinated care outside the acute care setting have emerged.

The survey estimates from the National Center for Health Statistics report that more people are vaccinating for flu and testing for HIV.

The physician community on Twitter is a vibrant, diverse one. But the platform's use in and out of the clinic is still subject to debate.

Hormone therapy taken soon after menopause may help prevent memory loss.

The industry has reached multibillion-dollar status, but more US patients seeking international care are driven by burden than opportunity.